Bio-Techne Launches Expanded Menu of RNAscope Probes for Human and Mouse Transcriptome to Advance Spatial Biology
Rhea-AI Summary
Bio-Techne (NASDAQ: TECH) has launched an expanded menu of RNAscope™ in situ hybridization probes for human and mouse transcriptome research. This expansion aims to advance spatial biology research and the development of next-generation therapeutics and diagnostics. The Advanced Cell Diagnostics (ACD) branded RNAscope probe portfolio now includes over 70,000 unique probes across more than 450 species. RNAscope is noted for its spatial precision, sensitivity, and specificity, providing a single-cell view of disease pathology and therapeutic response.
This expansion allows customers to accelerate the validation of new RNA biomarkers from single-cell genomics and spatial discovery programs. Available on bio-techne.com, customers can easily select RNAscope probes along with R&D Systems antibodies to study changes in cell phenotypes and functional states. The probes come in manual and automated formats, including compatibility with the Lunaphore COMET™ system, enabling seamless advancement from late discovery to translational research or clinical assay development.
Dr. Matt McManus, President of Bio-Techne's Diagnostics and Spatial Biology Segment, emphasized that the expanded portfolio, with over 12,000 citations in clinical and translational research, empowers customers to accelerate biomarker validation and improve lives.
Positive
- Launch of expanded RNAscope probe menu for human and mouse transcriptome.
- Over 70,000 unique probes across more than 450 species.
- Enables acceleration of new RNA biomarker validation.
- Available in manual and automated formats, including Lunaphore COMET™ system.
- Over 12,000 citations in clinical and translational research.
Negative
- None.
News Market Reaction
On the day this news was published, TECH declined 0.47%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Representing the most referenced spatial biology technology in the industry, RNAscope provides an unprecedented single-cell view of disease pathology and therapeutic response across a wide range of diseases.
Backed by the RNAscope probe guarantee, this new addition to the large and growing RNAscope probe menu enables customers to easily accelerate validation of new RNA biomarkers from single-cell genomics and spatial discovery programs. Available for purchase on bio-techne.com, customers can easily select RNAscope probes together with R&D Systems antibodies to further illuminate changes in cell phenotypes and functional states. With ready-to-use manual and automated formats available for each RNAscope probe, including for use on the automated Lunaphore COMET™ system, researchers can seamlessly advance new RNA and multiomic biomarkers from late discovery to translational research or clinical assay development using the same RNAscope probe design.
"Empowering our customers with precise and scalable solutions to advance translational research and precision medicine is central to our mission," said Dr. Matt McManus, President of Bio-Techne's Diagnostics and Spatial Biology Segment. "With over 12,000 citations in clinical and translational research combined, our expanded portfolio of gold-standard RNAscope probes enables customers to accelerate biomarker validation and ultimately improve lives."
About Bio-Techne
Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. They aid in drug discovery efforts and provide the means for accurate clinical tests and diagnoses. With hundreds of thousands of products in its portfolio, Bio-Techne generated approximately
About Bio-Techne Corporation (NASDAQ: TECH)
Contact: David Clair, Vice President, Investor Relations & Corporate Development
david.clair@bio-techne.com
612-656-4416
View original content to download multimedia:https://www.prnewswire.com/news-releases/bio-techne-launches-expanded-menu-of-rnascope-probes-for-human-and-mouse-transcriptome-to-advance-spatial-biology-302380023.html
SOURCE Bio-Techne Corporation
FAQ
What is the significance of Bio-Techne's expanded RNAscope probe menu?
How many unique RNAscope probes are included in Bio-Techne's expanded menu?
What are the benefits of Bio-Techne's RNAscope probes for researchers?
How can researchers purchase Bio-Techne's RNAscope probes?
What is the RNAscope probe guarantee?
What is the role of the Lunaphore COMET™ system in using RNAscope probes?
How many citations does Bio-Techne's RNAscope technology have in clinical and translational research?
